I don’t have a favorite biotech sector per se because my DD tends to be bottom-up rather than top-down. I currently hold a large position in MNTA (mostly acquired in 2007 at single-digit prices) and somewhat smaller positions in AGN, ABT, PKI, PFE, and MON. I’m thinking of building a position in EXAS, but I have a little more DD to do. Regards, Dew
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”